May 24, 2024, 14:53
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a post by Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals on X, adding:
“Really important discussion about this new guideline.”
Quoting Timothée Olivier’s post:
“Journal of Clinical Oncology updated their recommendation about adjuvant use of CDK4/6 inhibitors in early breast cancer.
Are patients protected enough?
See our analysis below.”
Additional information.
Source: Vinay Prasad/X and Timothée Olivier/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 30, 2024, 13:23
Dec 30, 2024, 12:58
Dec 30, 2024, 12:36